We are out today in JAMA Psychiatry with our NMA on psychotherapies for generalized anxiety disorder. Our analyses show that CBT should be considered a first-line treatment when considering the trade-offs between efficacy and acceptability, long-term effectiveness, and certainty in the level of evidence. Check it out!